Is Green Tea Cardiometabolic Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Green Tea Cardiometabolic Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - This systematic review and meta-analysis aimed to synthesize observational evidence on tea consumption and hypertension and to explore whether this association differed according to tea type, sex, age, region, and hypertension diagnostic threshold. [Jiang R (2026); evidence level 1] - In 16 cross-sectional studies, tea consumption was weakly associated with lower hypertension prevalence ( OR = 0.92, 95% CI : 0.87-0.97, I 2 = 62.8%). [Jiang R (2026); evidence level 1] - This inverse association was stronger for black tea drinkers, Asians, women, participants aged ORs of the four cohort studies indicated a 13% lower hypertension risk ( OR = 0.87, 95% CI : 0.84-0.92, I 2 = 31.9%). [Jiang R (2026); evidence level 1] - Objective The association between habitual tea consumption and hypertension remains controversial. [Jiang R (2026); evidence level 1] - Experimental studies provide substantial biological plausibility, while epidemiological studies have frequently associated habitual tea consumption with favorable cardiovascular outcomes. [Liu Rong (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.